| Elizabeth Ashleigh David, MD | |
|
12605 E 16th Ave, Aurora, CO 80045-2545 | |
| (720) 848-0000 | |
| Not Available |
| Full Name | Elizabeth Ashleigh David |
|---|---|
| Gender | Female |
| Speciality | Thoracic Surgery |
| Experience | 19 Years |
| Location | 12605 E 16th Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578714333 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Colorado Hospital Authority | Aurora, CO | Hospital |
| National Jewish Health | Denver, CO | Hospital |
| Saint Joseph Hospital | Denver, CO | Hospital |
| Uchealth Highlands Ranch Hospital | Highlands ranch, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| National Jewish Health | 4587577028 | 220 |
| University Physicians Incorporated | 3476465667 | 2657 |
News Archive
The Wall Street Journal examines how companies, facing higher insurance costs, are using office nurses to "nudge employees about long-term, expensive conditions." Meanwhile, heart studies probe where hospitals are building new angioplasty centers and how Medicare Advantage handles cardiac treatment.
Nearly one in three women who have breast cancer surgery will need to return to the operating room for additional surgery after the tumor is evaluated by a pathologist.
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.
› Verified 3 days ago
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
The Wall Street Journal examines how companies, facing higher insurance costs, are using office nurses to "nudge employees about long-term, expensive conditions." Meanwhile, heart studies probe where hospitals are building new angioplasty centers and how Medicare Advantage handles cardiac treatment.
Nearly one in three women who have breast cancer surgery will need to return to the operating room for additional surgery after the tumor is evaluated by a pathologist.
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.
› Verified 3 days ago
| Entity Name | National Jewish Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326015777 PECOS PAC ID: 4587577028 Enrollment ID: O20031110000757 |
News Archive
The Wall Street Journal examines how companies, facing higher insurance costs, are using office nurses to "nudge employees about long-term, expensive conditions." Meanwhile, heart studies probe where hospitals are building new angioplasty centers and how Medicare Advantage handles cardiac treatment.
Nearly one in three women who have breast cancer surgery will need to return to the operating room for additional surgery after the tumor is evaluated by a pathologist.
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Ashleigh David, MD Po Box 110429, Aurora, CO 80042-0429 Ph: () - | Elizabeth Ashleigh David, MD 12605 E 16th Ave, Aurora, CO 80045-2545 Ph: (720) 848-0000 |
News Archive
The Wall Street Journal examines how companies, facing higher insurance costs, are using office nurses to "nudge employees about long-term, expensive conditions." Meanwhile, heart studies probe where hospitals are building new angioplasty centers and how Medicare Advantage handles cardiac treatment.
Nearly one in three women who have breast cancer surgery will need to return to the operating room for additional surgery after the tumor is evaluated by a pathologist.
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.
› Verified 3 days ago
Dr. Jason Zakko, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 954-993-2252 | |
Emily A Downs, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Max Mitchell, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Frederick Grover, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
James Jaggers, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Thomas Reece, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Alexander F. Pak, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1444 S Potomac St Ste 200, Aurora, CO 80012 Phone: 303-226-4641 Fax: 303-751-6069 |